RecruitingNot ApplicableNCT07296939

Youth Emotional and Behavioral Treatment Study

Psychological Assessment and Treatment of Youth Emotional and Behavioral Dysregulation


Sponsor

Florida State University

Enrollment

500 participants

Start Date

Apr 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to characterize key mechanisms underlying the development, maintenance, and treatment of severe irritability in a clinically heterogeneous sample of school-aged youth.


Eligibility

Min Age: 4 YearsMax Age: 17 Years

Plain Language Summary

Simplified for easier understanding

This study tests therapy approaches for children and teenagers who have anxiety, mood disorders, or serious emotional and behavioral problems, with the goal of finding better treatments for young people struggling with these conditions. **You may be eligible if...** - Your child is between 4 and 17 years old - Your child has been diagnosed with an anxiety or mood disorder, OR has clinically significant irritability, emotional dysregulation, or disruptive behavior - Both you and your child are able to understand and communicate in the language used in the study **You may NOT be eligible if...** - Your child has a primary diagnosis of autism spectrum disorder or intellectual disability - Your child is currently in active psychiatric crisis - You or your child cannot participate in the required assessments or sessions Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALCognitive Behavioral Therapy

Participants will receive evidence-based treatment designed to address a wide range of emotional disorders.


Locations(1)

Florida State University

Tallahassee, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07296939


Related Trials